Literature DB >> 2612511

Exogenous prostaglandin administration and pseudo-Bartter syndrome.

J P Langhendries1, V Thiry, E Bodart, G Delfosse, L Whitofs, O Battisti, J M Bertrand.   

Abstract

Biological abnormalities simulating Bartter syndrome were observed in a preterm neonate with complex cyanotic congenital heart disease, for which ductus arteriosus was maintained open by high doses of prostaglandin (PG) until a Blalock shunt could be performed. These abnormalities spontaneously disappeared after cessation of PG administration. We postulate that the natriuretic effect of exogenous administered PG could further increase sodium wasting already induced by the cardiopathy thus leading to pseudo-Bartter syndrome.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612511     DOI: 10.1007/bf01958284

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

1.  Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome.

Authors:  F C BARTTER; P PRONOVE; J R GILL; R C MACCARDLE
Journal:  Am J Med       Date:  1962-12       Impact factor: 4.965

2.  The pathophysiology of Bartter syndrome.

Authors:  N A Kurtzman; L F Gutierrez
Journal:  JAMA       Date:  1975-11-17       Impact factor: 56.272

3.  Treatment of childhood Bartter's syndrome with indomethacin.

Authors:  J M Littlewood; M R Lee; S R Meadow
Journal:  Lancet       Date:  1976-10-09       Impact factor: 79.321

4.  Independent roles of prostaglandins and the renin-angiotensin system in abnormal vascular reactivity in Bartter's syndrome.

Authors:  T Fujita; K Ando; Y Sato; K Yamashita; M Nomura; T Fukui
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

5.  Surreptitious diuretic ingestion and pseudo-Bartter's syndrome.

Authors:  R L Jamison; J C Ross; R L Kempson; C R Sufit; T E Parker
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

Review 6.  Role of prostaglandins in the pathogenesis of Bartter's syndrome.

Authors:  M P Fichman; N Telfer; P Zia; P Speckart; M Golub; R Rude
Journal:  Am J Med       Date:  1976-05-31       Impact factor: 4.965

7.  Urinary catecholamine excretion by various age groups with special reference to clinical value of measuring catecholamines in newborns.

Authors:  T Nakai; R Yamada
Journal:  Pediatr Res       Date:  1983-06       Impact factor: 3.756

8.  Electrolyte composition of the amniotic fluid in Bartter syndrome.

Authors:  G Massa; W Proesmans; H Devlieger; K Vandenberghe; A Van Assche; E Eggermont
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1987-04       Impact factor: 2.435

9.  Excretion of catecholamine in urine by infants and children with cyanotic congenital heart disease.

Authors:  G M Folger; J G Hollowell
Journal:  Pediatr Res       Date:  1972-03       Impact factor: 3.756

10.  Bartter's syndrome--the case for a primary potassium-losing tubulopathy: discussion paper.

Authors:  J Costello; E Bourke
Journal:  J R Soc Med       Date:  1983-01       Impact factor: 18.000

View more
  2 in total

1.  Pseudo-Bartter syndrome in a pregnant mother and her fetus.

Authors:  Mikael Mathot; Pierre Maton; Elisabeth Henrion; Anne François-Adant; Arnaud Marguglio; Stéphanie Gaillez; Laure Collard; Jean-Paul Langhendries
Journal:  Pediatr Nephrol       Date:  2006-05-30       Impact factor: 3.714

2.  Pseudo-Bartter syndrome in a neonate on prostaglandin infusion.

Authors:  Sofie Vanhaesebrouck; Karel Allegaert; Christine Vanhole; Hugo Devlieger; Marc Gewillig; Willem Proesmans
Journal:  Eur J Pediatr       Date:  2003-06-17       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.